Clinical trials

  • FWY003 TOSILATE for Geographic atrophy secondary to age-related macular degeneration | Dry age-related macular degeneration
  • IGG-LIKE T CELL ENGAGER BINDING TO DLL3 AND CD3 for Extrapulmonary neuroendocrine carcinoma (advanced or metastatic)
  • MEN2501 for Platinum-resistant ovarian cancer | Ovarian cancer
  • Allogenic adipose-tissue-derived mesenchymal stem cells for Autism spectrum disorder | Gastrointestinal symptoms
  • Avelumab for Metastatic urothelial carcinoma
  • NTRX-07 for Neuroinflammation-related diseases | Alzheimer's disease
  • RPTR-1-201 for Advanced solid tumor
  • OXALIPLATIN for Locally advanced rectal cancer
  • LESIGERCEPT for Chronic spontaneous urticaria
  • tozorakimab for Chronic obstructive pulmonary disease (COPD)
  • METHENAMINE HIPPURATE for Recurrent urinary tract infection
  • EXEMESTANE for Early breast cancer | Hormone receptor-positive HER2-negative breast cancer | Luminal A breast cancer